FDA.reportPublic FDA data

Application 020815

Type
NDA
Sponsor
LILLY

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001EVISTARALOXIFENE HYDROCHLORIDETABLET;ORAL60MGYesYes

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0002-4184EvistaRaloxifene hydrochlorideEli Lilly and CompanyNDACurrent
0002-4184EvistaRaloxifene hydrochlorideEli Lilly and CompanyNDACurrent
0002-4184EvistaRaloxifene hydrochlorideEli Lilly and CompanyNDACurrent
0002-4184EvistaRaloxifene hydrochlorideEli Lilly and CompanyNDACurrent
0002-4184EvistaRaloxifene hydrochlorideEli Lilly and CompanyNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
54842SUPPL2018-07-06
54755SUPPL2018-07-05
41718ORIG2009-12-03
43680ORIG2009-11-18
3407SUPPL2007-09-25
35397SUPPL2007-07-24
25888SUPPL2007-07-24
41719SUPPL1999-09-30
25887SUPPL1999-09-30
13471SUPPL1999-09-30
20973SUPPL1998-11-24